This paper is in the following e-collection/theme issue:

Participatory Research Protocols and Proposals (138) Precision Medicine (74) Infectious Diseases (non-STD/STI) (1564) Influenza and Influenza-Like-Illness (ILI) Surveillance (216) Clinical Information and Decision Making (1392)

Published on in Vol 13 (2024)

This is a member publication of University of Oxford (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56271, first published .
Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study

Authors of this article:

Meredith Leston1 Author Orcid Image ;   José Ordóñez-Mena1 Author Orcid Image ;   Mark Joy1 Author Orcid Image ;   Simon de Lusignan1 Author Orcid Image ;   Richard Hobbs1 Author Orcid Image ;   Iain McInnes2 Author Orcid Image ;   Lennard Lee3 Author Orcid Image
Article Authors Cited by Tweetations (4) Metrics

Meredith Leston   1 , BA, MPH ;   José Ordóñez-Mena   1 , PhD ;   Mark Joy   1 , PhD ;   Simon de Lusignan   1 , MBBS ;   Richard Hobbs   1 , MBChB ;   Iain McInnes   2 , BSc, MBChB, PhD ;   Lennard Lee   3 , BMBCh, DPhil

1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

2 Wolfson Medical School Building, University of Glasgow, Glasgow, United Kingdom

3 Department of Oncology, University of Oxford, Oxford, United Kingdom

Corresponding Author:

  • Meredith Leston, BA, MPH
  • Nuffield Department of Primary Care Health Sciences
  • University of Oxford
  • Radcliffe Primary Care Building
  • Woodstock Road
  • Oxford, OX2 6GG
  • United Kingdom
  • Phone: 44 7896980320
  • Email: meredith.leston@phc.ox.ac.uk